抗磷脂综合征(临床一例)

Bruno Sousa
{"title":"抗磷脂综合征(临床一例)","authors":"Bruno Sousa","doi":"10.19277/bbr.19.2.292","DOIUrl":null,"url":null,"abstract":"40-year-old woman, unemployed. She sought Nutrition Consultation for nutritional control, as she was taking oral anticoagulant therapy. No other pathologies requiring nutritional therapy, but she wanted to lose a little weight. She is followed in the Thrombophilia Consultation for Antiphospholipid Syndrome (APS) for mutation of the prothrombin gene in heterozygosity. She takes warfarin as an oral anticoagulant, with INR (International Normalized Ratio) control.","PeriodicalId":14771,"journal":{"name":"Journal Biomedical and Biopharmaceutical Research","volume":"44 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Antiphospholipid Syndrome (Clinical case)\",\"authors\":\"Bruno Sousa\",\"doi\":\"10.19277/bbr.19.2.292\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"40-year-old woman, unemployed. She sought Nutrition Consultation for nutritional control, as she was taking oral anticoagulant therapy. No other pathologies requiring nutritional therapy, but she wanted to lose a little weight. She is followed in the Thrombophilia Consultation for Antiphospholipid Syndrome (APS) for mutation of the prothrombin gene in heterozygosity. She takes warfarin as an oral anticoagulant, with INR (International Normalized Ratio) control.\",\"PeriodicalId\":14771,\"journal\":{\"name\":\"Journal Biomedical and Biopharmaceutical Research\",\"volume\":\"44 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal Biomedical and Biopharmaceutical Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.19277/bbr.19.2.292\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal Biomedical and Biopharmaceutical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.19277/bbr.19.2.292","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

40岁的女性,失业。她寻求营养咨询以控制营养,因为她正在服用口服抗凝治疗。没有其他疾病需要营养治疗,但她想减肥。由于凝血酶原基因杂合性突变,她在抗磷脂综合征(APS)的血栓病会诊中被跟踪。她服用华法林口服抗凝剂,控制INR(国际标准化比率)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Antiphospholipid Syndrome (Clinical case)
40-year-old woman, unemployed. She sought Nutrition Consultation for nutritional control, as she was taking oral anticoagulant therapy. No other pathologies requiring nutritional therapy, but she wanted to lose a little weight. She is followed in the Thrombophilia Consultation for Antiphospholipid Syndrome (APS) for mutation of the prothrombin gene in heterozygosity. She takes warfarin as an oral anticoagulant, with INR (International Normalized Ratio) control.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信